Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

British journal of cancer

Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA.
PMID: 27228292
Br J Cancer. 2016 Jun 14;114(12):e17. doi: 10.1038/bjc.2016.137. Epub 2016 May 26.

No abstract available.

Cite
Phillips RS, Sung L, Ammann RA, et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer. 2016;114(12):e17doi: 10.1038/bjc.2016.137.
Phillips, R. S., Sung, L., Ammann, R. A., Riley, R. D., Castagnola, E., Haeusler, G. M., Klaassen, R., Tissing, W. J., Lehrnbecher, T., Chisholm, J., Hakim, H., Ranasinghe, N., Paesmans, M., Hann, I. M., & Stewart, L. A. (2016). Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. British journal of cancer, 114(12), e17. https://doi.org/10.1038/bjc.2016.137
Phillips, Robert S, et al. "Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis." British journal of cancer vol. 114,12 (2016): e17. doi: https://doi.org/10.1038/bjc.2016.137
Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer. 2016 Jun 14;114(12):e17. doi: 10.1038/bjc.2016.137. Epub 2016 May 26. PMID: 27228292; PMCID: PMC4984466.
Copy Download .nbib Format: NLM
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response.

British journal of haematology

Sassen SDT, Mathôt RAA, Pieters R, de Haas V, Kaspers GJL, van den Bos C, Tissing WJE, Te Loo DMWW, Bierings MB, van der Sluis IM, Zwaan CM.
PMID: 34060065
Br J Haematol. 2021 Jul;194(2):423-432. doi: 10.1111/bjh.17572. Epub 2021 Jun 01.

Glucocorticoids form the backbone of paediatric acute lymphoblastic leukaemia (ALL) treatment. Many studies have been performed on steroid resistance; however, few studies have addressed the relationship between dose, concentration and clinical response. The aim of the present study was...

Cite
Sassen SDT, Mathôt RAA, Pieters R, et al. Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response. Br J Haematol. 2021;194(2):423-432doi: 10.1111/bjh.17572.
Sassen, S. D. T., Mathôt, R. A. A., Pieters, R., de Haas, V., Kaspers, G. J. L., van den Bos, C., Tissing, W. J. E., Te Loo, D. M. W. W., Bierings, M. B., van der Sluis, I. M., & Zwaan, C. M. (2021). Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response. British journal of haematology, 194(2), 423-432. https://doi.org/10.1111/bjh.17572
Sassen, Sebastiaan D T, et al. "Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response." British journal of haematology vol. 194,2 (2021): 423-432. doi: https://doi.org/10.1111/bjh.17572
Sassen SDT, Mathôt RAA, Pieters R, de Haas V, Kaspers GJL, van den Bos C, Tissing WJE, Te Loo DMWW, Bierings MB, van der Sluis IM, Zwaan CM. Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response. Br J Haematol. 2021 Jul;194(2):423-432. doi: 10.1111/bjh.17572. Epub 2021 Jun 01. PMID: 34060065; PMCID: PMC8362215.
Copy Download .nbib Format: NLM
Taste function in children: normative values and associated factors.

Pediatric research

van den Brink M, IJpma I, Fiocco M, Tissing WJE, Havermans RC.
PMID: 34963699
Pediatr Res. 2021 Dec 28; doi: 10.1038/s41390-021-01920-w. Epub 2021 Dec 28.

BACKGROUND: Although less frequent than in adults, taste loss also occurs in childhood. "Taste Strips" are frequently used for diagnosing taste dysfunction; however, normative values are lacking for children. In this study, we will create normative values for the...

Cite
van den Brink M, IJpma I, Fiocco M, et al. Taste function in children: normative values and associated factors. Pediatr Res. 2021;doi: 10.1038/s41390-021-01920-w.
van den Brink, M., IJpma, I., Fiocco, M., Tissing, W. J. E., & Havermans, R. C. (2021). Taste function in children: normative values and associated factors. Pediatric research, . https://doi.org/10.1038/s41390-021-01920-w
van den Brink, Mirjam, et al. "Taste function in children: normative values and associated factors." Pediatric research vol. (2021). doi: https://doi.org/10.1038/s41390-021-01920-w
van den Brink M, IJpma I, Fiocco M, Tissing WJE, Havermans RC. Taste function in children: normative values and associated factors. Pediatr Res. 2021 Dec 28; doi: 10.1038/s41390-021-01920-w. Epub 2021 Dec 28. PMID: 34963699.
Copy Download .nbib Format: NLM
Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Simon JDHP, Schepers SA, Grootenhuis MA, Mensink M, Huitema AD, Tissing WJE, Michiels EMC.
PMID: 34136954
Support Care Cancer. 2021 Dec;29(12):7617-7626. doi: 10.1007/s00520-021-06357-9. Epub 2021 Jun 16.

PURPOSE: This study assessed adherence to, feasibility of, and barriers and facilitators of implementation of an app developed to monitor and follow-up with pain in children with cancer at home.METHODS: Children (8-18 years) receiving cancer treatment (all diagnoses) or...

Cite
Simon JDHP, Schepers SA, Grootenhuis MA, et al. Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app. Support Care Cancer. 2021;29(12):7617-7626doi: 10.1007/s00520-021-06357-9.
Simon, J. D. H. P., Schepers, S. A., Grootenhuis, M. A., Mensink, M., Huitema, A. D., Tissing, W. J. E., & Michiels, E. M. C. (2021). Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(12), 7617-7626. https://doi.org/10.1007/s00520-021-06357-9
Simon, Julia D H P, et al. "Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 29,12 (2021): 7617-7626. doi: https://doi.org/10.1007/s00520-021-06357-9
Simon JDHP, Schepers SA, Grootenhuis MA, Mensink M, Huitema AD, Tissing WJE, Michiels EMC. Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app. Support Care Cancer. 2021 Dec;29(12):7617-7626. doi: 10.1007/s00520-021-06357-9. Epub 2021 Jun 16. PMID: 34136954; PMCID: PMC8550558.
Copy Download .nbib Format: NLM
Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study.

Neuro-oncology advances

Meijer AJM, Fiocco MF, Janssens GO, Clemens E, Tissing WJE, Loonen JJ, van Dulmen-den Broeder E, de Vries ACH, Bresters D, Versluys B, Ronckers CM, Kremer LCM, van der Pal HJ, Neggers SJCMM, van der Heiden-van der Loo M, Stokroos RJ, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM.
PMID: 33196041
Neurooncol Adv. 2020 Sep 15;2(1):vdaa122. doi: 10.1093/noajnl/vdaa122. eCollection 2020.

BACKGROUND: Tinnitus is a serious late effect of childhood cancer treatment. The aim of this study was to determine the occurrence and risk factors for tinnitus in a national cohort of childhood cancer survivors (CCS).METHODS: Data were collected within...

Cite
Meijer AJM, Fiocco MF, Janssens GO, et al. Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neurooncol Adv. 2020;2(1):vdaa122doi: 10.1093/noajnl/vdaa122.
Meijer, A. J. M., Fiocco, M. F., Janssens, G. O., Clemens, E., Tissing, W. J. E., Loonen, J. J., van Dulmen-den Broeder, E., de Vries, A. C. H., Bresters, D., Versluys, B., Ronckers, C. M., Kremer, L. C. M., van der Pal, H. J., Neggers, S. J. C. M. M., van der Heiden-van der Loo, M., Stokroos, R. J., Hoetink, A. E., van Grotel, M., & van den Heuvel-Eibrink, M. M. (2020). Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neuro-oncology advances, 2(1), vdaa122. https://doi.org/10.1093/noajnl/vdaa122
Meijer, Annelot J M, et al. "Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study." Neuro-oncology advances vol. 2,1 (2020): vdaa122. doi: https://doi.org/10.1093/noajnl/vdaa122
Meijer AJM, Fiocco MF, Janssens GO, Clemens E, Tissing WJE, Loonen JJ, van Dulmen-den Broeder E, de Vries ACH, Bresters D, Versluys B, Ronckers CM, Kremer LCM, van der Pal HJ, Neggers SJCMM, van der Heiden-van der Loo M, Stokroos RJ, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM. Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neurooncol Adv. 2020 Sep 15;2(1):vdaa122. doi: 10.1093/noajnl/vdaa122. eCollection 2020. PMID: 33196041; PMCID: PMC7648591.
Copy Download .nbib Format: NLM
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.

Data in brief

Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O.
PMID: 32939381
Data Brief. 2020 Aug 24;32:106227. doi: 10.1016/j.dib.2020.106227. eCollection 2020 Oct.

Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (

Cite
Langer T, Clemens E, Broer L, et al. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020;32:106227doi: 10.1016/j.dib.2020.106227.
Langer, T., Clemens, E., Broer, L., Maier, L., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Pluijm, S. F. M., Binder, H., Mayer, B., von dem Knesebeck, A., Byrne, J., van Dulmen-den Broeder, E., Crocco, M., Grabow, D., Kaatsch, P., Kaiser, M., Spix, C., Kenborg, L., Winther, J. F., Rechnitzer, C., Hasle, H., Kepak, T., van der Kooi, A. F., Kremer, L. C., Kruseova, J., Bielack, S., Sorg, B., Hecker-Nolting, S., Kuehni, C. E., Ansari, M., Kompis, M., van der Pal, H. J., Parfitt, R., Deuster, D., Matulat, P., Tillmanns, A., Tissing, W. J. E., Beck, J. D., Elsner, S., Am Zehnhoff-Dinnesen, A., van den Heuvel-Eibrink, M. M., Zolk, O. (2020). Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief, 32106227. https://doi.org/10.1016/j.dib.2020.106227
Langer, Thorsten, et al. "Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset." Data in brief vol. 32 (2020): 106227. doi: https://doi.org/10.1016/j.dib.2020.106227
Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020 Aug 24;32:106227. doi: 10.1016/j.dib.2020.106227. eCollection 2020 Oct. PMID: 32939381; PMCID: PMC7477761.
Copy Download .nbib Format: NLM
The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Loeffen EAH, Kremer LCM, Mulder RL, Font-Gonzalez A, Dupuis LL, Sung L, Robinson PD, van de Wetering MD, Tissing WJE.
PMID: 27928642
Support Care Cancer. 2017 Apr;25(4):1121-1125. doi: 10.1007/s00520-016-3501-y. Epub 2016 Dec 08.

As cure rates in pediatric oncology have improved substantially over the last decades, supportive care has become increasingly important to reduce morbidity and mortality and improve quality of life in children with cancer. Currently, large variations exist in pediatric...

Cite
Loeffen EAH, Kremer LCM, Mulder RL, et al. The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation. Support Care Cancer. 2016;25(4):1121-1125doi: 10.1007/s00520-016-3501-y.
Loeffen, E. A. H., Kremer, L. C. M., Mulder, R. L., Font-Gonzalez, A., Dupuis, L. L., Sung, L., Robinson, P. D., van de Wetering, M. D., & Tissing, W. J. E. (2017). The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 25(4), 1121-1125. https://doi.org/10.1007/s00520-016-3501-y
Loeffen, E A H, et al. "The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 25,4 (2017): 1121-1125. doi: https://doi.org/10.1007/s00520-016-3501-y
Loeffen EAH, Kremer LCM, Mulder RL, Font-Gonzalez A, Dupuis LL, Sung L, Robinson PD, van de Wetering MD, Tissing WJE. The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation. Support Care Cancer. 2017 Apr;25(4):1121-1125. doi: 10.1007/s00520-016-3501-y. Epub 2016 Dec 08. PMID: 27928642; PMCID: PMC5321691.
Copy Download .nbib Format: NLM
Management of globus pharyngeus.

International journal of otolaryngology

Kortequee S, Karkos PD, Atkinson H, Sethi N, Sylvester DC, Harar RS, Sood S, Issing WJ.
PMID: 23935629
Int J Otolaryngol. 2013;2013:946780. doi: 10.1155/2013/946780. Epub 2013 Jul 11.

Globus pharyngeus is a common ENT condition. This paper reviews the current evidence on globus and gives a rational guide to the management of patients with globus. The aetiology of globus is still unclear though most ENT surgeons believe...

Cite
Kortequee S, Karkos PD, Atkinson H, et al. Management of globus pharyngeus. Int J Otolaryngol. 2013;2013:946780doi: 10.1155/2013/946780.
Kortequee, S., Karkos, P. D., Atkinson, H., Sethi, N., Sylvester, D. C., Harar, R. S., Sood, S., & Issing, W. J. (2013). Management of globus pharyngeus. International journal of otolaryngology, 2013946780. https://doi.org/10.1155/2013/946780
Kortequee, S, et al. "Management of globus pharyngeus." International journal of otolaryngology vol. 2013 (2013): 946780. doi: https://doi.org/10.1155/2013/946780
Kortequee S, Karkos PD, Atkinson H, Sethi N, Sylvester DC, Harar RS, Sood S, Issing WJ. Management of globus pharyngeus. Int J Otolaryngol. 2013;2013:946780. doi: 10.1155/2013/946780. Epub 2013 Jul 11. PMID: 23935629; PMCID: PMC3725834.
Copy Download .nbib Format: NLM
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study.

JMIR research protocols

Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, de Vries A, Kuehni CE, Garrè ML, Kepak T, Kruseova J, Winther JF, Kremer LC, van Dulmen-den Broeder E, Tissing WJ, Rechnitzer C, Kenborg L, Hasle H, Grabow D, Parfitt R, Binder H, Carleton BC, Byrne J, Kaatsch P, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM.
PMID: 30888333
JMIR Res Protoc. 2019 Mar 19;8(3):e11868. doi: 10.2196/11868.

BACKGROUND: Survival rates after childhood cancer now reach nearly 80% in developed countries. However, treatments that lead to survival and cure can cause serious adverse effects with lifelong negative impacts on survivor quality of life. Hearing impairment is a...

Cite
Clemens E, Meijer AJ, Broer L, et al. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR Res Protoc. 2019;8(3):e11868doi: 10.2196/11868.
Clemens, E., Meijer, A. J., Broer, L., Langer, T., van der Kooi, A. L., Uitterlinden, A. G., de Vries, A., Kuehni, C. E., Garrè, M. L., Kepak, T., Kruseova, J., Winther, J. F., Kremer, L. C., van Dulmen-den Broeder, E., Tissing, W. J., Rechnitzer, C., Kenborg, L., Hasle, H., Grabow, D., Parfitt, R., Binder, H., Carleton, B. C., Byrne, J., Kaatsch, P., Am Zehnhoff-Dinnesen, A., Zolk, O., & van den Heuvel-Eibrink, M. M. (2019). Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR research protocols, 8(3), e11868. https://doi.org/10.2196/11868
Clemens, Eva, et al. "Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study." JMIR research protocols vol. 8,3 (2019): e11868. doi: https://doi.org/10.2196/11868
Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, de Vries A, Kuehni CE, Garrè ML, Kepak T, Kruseova J, Winther JF, Kremer LC, van Dulmen-den Broeder E, Tissing WJ, Rechnitzer C, Kenborg L, Hasle H, Grabow D, Parfitt R, Binder H, Carleton BC, Byrne J, Kaatsch P, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR Res Protoc. 2019 Mar 19;8(3):e11868. doi: 10.2196/11868. PMID: 30888333; PMCID: PMC6444213.
Copy Download .nbib Format: NLM
Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper.

Pediatric blood & cancer

Dupuis LL, Robinson PD, van de Wetering MD, Tissing W, Seelisch J, Digout C, Sung L, Phillips R.
PMID: 31975542
Pediatr Blood Cancer. 2020 Apr;67(4):e28170. doi: 10.1002/pbc.28170. Epub 2020 Jan 23.

Terms used to label types of clinical recommendations and guidance are applied inconsistently and do not reflect the methods used to create each type. Here, the international Pediatric Oncology Supportive Care Guideline Network proposes a lexicon for types of...

Cite
Dupuis LL, Robinson PD, van de Wetering MD, et al. Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper. Pediatr Blood Cancer. 2020;67(4):e28170doi: 10.1002/pbc.28170.
Dupuis, L. L., Robinson, P. D., van de Wetering, M. D., Tissing, W., Seelisch, J., Digout, C., Sung, L., Phillips, R. (2020). Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper. Pediatric blood & cancer, 67(4), e28170. https://doi.org/10.1002/pbc.28170
Dupuis, L Lee, et al. "Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper." Pediatric blood & cancer vol. 67,4 (2020): e28170. doi: https://doi.org/10.1002/pbc.28170
Dupuis LL, Robinson PD, van de Wetering MD, Tissing W, Seelisch J, Digout C, Sung L, Phillips R. Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper. Pediatr Blood Cancer. 2020 Apr;67(4):e28170. doi: 10.1002/pbc.28170. Epub 2020 Jan 23. PMID: 31975542.
Copy Download .nbib Format: NLM
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.

Cancers

van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium.
PMID: 34572825
Cancers (Basel). 2021 Sep 13;13(18). doi: 10.3390/cancers13184598.

CONCLUSIONS: Female CCSs

Cite
van der Perk MEM, Broer L, Yasui Y, et al. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel). 2021;13(18)doi: 10.3390/cancers13184598.
van der Perk, M. E. M., Broer, L., Yasui, Y., Robison, L. L., Hudson, M. M., Laven, J. S. E., van der Pal, H. J., Tissing, W. J. E., Versluys, B., Bresters, D., Kaspers, G. J. L., de Vries, A. C. H., Lambalk, C. B., Overbeek, A., Loonen, J. J., Beerendonk, C. C. M., Byrne, J., Berger, C., Clemens, E., Dirksen, U., Falck Winther, J., Fosså, S. D., Grabow, D., Muraca, M., Kaiser, M., Kepák, T., Kruseova, J., Modan-Moses, D., Spix, C., Zolk, O., Kaatsch, P., Krijthe, J. H., Kremer, L. C. M., Brooke, R. J., Baedke, J. L., van Schaik, R. H. N., van den Anker, J. N., Uitterlinden, A. G., Bos, A. M. E., van Leeuwen, F. E., van Dulmen-den Broeder, E., van der Kooi, A. L. F., van den Heuvel-Eibrink, M. M., & On Behalf Of The PanCareLIFE Consortium. (2021). Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers, 13(18), . https://doi.org/10.3390/cancers13184598
van der Perk, M E Madeleine, et al. "Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study." Cancers vol. 13,18 (2021). doi: https://doi.org/10.3390/cancers13184598
van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel). 2021 Sep 13;13(18). doi: 10.3390/cancers13184598. PMID: 34572825; PMCID: PMC8470074.
Copy Download .nbib Format: NLM
Body composition of patients with neuroblastoma using computed tomography.

Pediatric blood & cancer

IJpma I, Lequin MH, Nievelstein RAJ, Fiocco M, Tissing WJE.
PMID: 34606163
Pediatr Blood Cancer. 2021 Dec;68(12):e29337. doi: 10.1002/pbc.29337. Epub 2021 Oct 04.

BACKGROUND: Computed tomography (CT) is often used to investigate muscle and fat mass in adult patients with cancer. However, this method has rarely been used in the pediatric cancer population. The present retrospective study aimed to investigate changes in...

Cite
IJpma I, Lequin MH, Nievelstein RAJ, et al. Body composition of patients with neuroblastoma using computed tomography. Pediatr Blood Cancer. 2021;68(12):e29337doi: 10.1002/pbc.29337.
IJpma, I., Lequin, M. H., Nievelstein, R. A. J., Fiocco, M., & Tissing, W. J. E. (2021). Body composition of patients with neuroblastoma using computed tomography. Pediatric blood & cancer, 68(12), e29337. https://doi.org/10.1002/pbc.29337
IJpma, Irene, et al. "Body composition of patients with neuroblastoma using computed tomography." Pediatric blood & cancer vol. 68,12 (2021): e29337. doi: https://doi.org/10.1002/pbc.29337
IJpma I, Lequin MH, Nievelstein RAJ, Fiocco M, Tissing WJE. Body composition of patients with neuroblastoma using computed tomography. Pediatr Blood Cancer. 2021 Dec;68(12):e29337. doi: 10.1002/pbc.29337. Epub 2021 Oct 04. PMID: 34606163.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries